RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA
Clinical trials for RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA trials appear
Sign up with your email to follow new studies for RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo aims to boost transplant success in tough lymphoma
Disease control Recruiting nowThis study tests whether a lower dose of the drug epcoritamab, combined with two chemotherapy drugs (gemcitabine and oxaliplatin), can shrink tumors in people with diffuse large B-cell lymphoma that has come back or not responded to prior treatment. The 10 participants must be el…
Matched conditions: RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA
Phase: PHASE2 • Sponsor: Hospital Universitario Dr. Jose E. Gonzalez • Aim: Disease control
Last updated May 26, 2026 11:27 UTC
-
New hope for aggressive blood cancer: experimental combo enters final testing phase
Disease control Recruiting nowThis study tests whether adding the experimental drug HMPL-760 to standard chemotherapy (R-GemOx) can help control diffuse large B-cell lymphoma that has come back or stopped responding to treatment. About 240 adults will take part. The goal is to see if the combination slows can…
Matched conditions: RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA
Phase: PHASE3 • Sponsor: Hutchmed • Aim: Disease control
Last updated May 20, 2026 11:56 UTC